Profile   |  Career Opportunities
Malaysia has a well-developed healthcare infrastructure. With strong economic growth, we see an increasing trend in healthcare spending. Besides, the growing number of foreigners seeking treatment in Malaysia has also increased the demand for quality pharmaceuticals.

Espicom Business Intelligence estimated that the market value will surpass the US$1 billion mark by 2009. By 2013, it will reach US$1.5 billion, or US$49 per capita.

Strength
Our sales and marketing operations in Malaysia function through a wholly owned subsidiary, PM-Hyphens Pharmaceuticals Sdn. Bhd. based in Kuala Lumpur. While operational support is provided by the Singapore management, the national distribution system is established via partnership with Apex Pharmacy Marketing Sdn. Bhd.

Today, our team covers ophthalmologists, ENT specialists, OB/GYNs, pediatricians and private general practitioners with products like bioXtra®, Gynofort™, Snoreeze®, Staloral®, Sterimar® and Minims®. Other key products are pending approvals.